Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British Journal of Pharmacology

• Publication date

  2001-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0704260PMID 11564660PMCID PMC1572957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of ezetimibe on serum concentrations of lipid-soluble vitamins

  2001influential reference
• Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters.

  2001cited by this paper
• The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys.

  2001cited by this paper
• PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

  2000cited by this paper
• Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.

  2000cited by this paper
• Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

  2000cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

  2000cited by this paper
• Intestinal cholesterol absorption.

  1999cited by this paper
• Dietary cholesterol and the mechanisms of cholesterol absorption

  1999cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption.

  1998cited by this paper
• Inhibition of ileal Na+/bile acid cotransporter by S-8921 reduces serum cholesterol and prevents atherosclerosis in rabbits.

  1998cited by this paper
• In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461.

  1997influential reference
• Established and Emerging Strategies for Inhibition of Cholesterol Absorption

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Postprandial lipoprotein metabolism and atherosclerosis.

  1995cited by this paper
• Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.

  1995cited by this paper
• Postprandial lipoprotein metabolism and atherosclerosis

  1995cited by this paper
• The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.

  1995influential reference
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• The effect of pancreatic diversion on lymphatic absorption and esterification of cholesterol in the rat.

  1981influential reference
• Role of pancreatic digestion in cholesterol absorption.

  1957cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957influential reference

• Lysophosphatidylcholine as a mechanistic and therapeutic nexus in atherosclerotic cardiovascular disease.

  2026cites this paper
• Important role of OATP in the liver disposition of ezetimibe and its consequent glucuronidation metabolite.

  2025cites this paper
• Spectrophotometric-Chemometric Method for the Quantitative Determination of Two-Component Cholesterol Drugs

  2025cites this paper
• Pediatric Familial Hypercholesterolemia: Targeting Intestinal Absorption and Other Therapeutic Strategies

  2025cites this paper
• Effectiveness and Safety of Very-Low-Dose Rosuvastatin–Ezetimibe Therapy in Korean Patients with Dyslipidaemia: A Multicentre Prospective Observational Study

  2025cites this paper
• Potential lipid-lowering effects of Northern Thai vegetable extracts on the inhibition of cholesterol absorption: emerging in vitro and in vivo models.

  2025cites this paper
• Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease

  2024cites this paper
• The TICE Pathway: Mechanisms and Potential Clinical Applications

  2023cites this paper
• In silico identification of modulators of J domain protein-Hsp70 interactions in Plasmodium falciparum: a drug repurposing strategy against malaria

  2023cites this paper
• Hydroxyurea ameliorates atherosclerosis in ApoE-/- mice by potentially modulating Niemann-Pick C1-like 1 protein through the gut microbiota

  2022cites this paper
• Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption.

  2022cites this paper
• Dyslipidemia in Women: Etiology and Management

  2021cites this paper
• Synthesis of 3-Amino-4-substituted Monocyclic ß-Lactams—Important Structural Motifs in Medicinal Chemistry

  2021cites this paper
• Atherosclerosis: Cholesterol Management

  2021cites this paper
• Ezetimibe blocks Toxoplasma gondii-, Neospora caninum- and Besnoitia besnoiti-tachyzoite infectivity and replication in primary bovine endothelial host cells

  2021cites this paper
• Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats

  2021cites this paper
• Therapeutic Lipidology

  2021influential citation
• A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

  2020cites this paper
• Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins, and Plant Sterols

  2020cites this paper
• Ezetimibe promotes CYP7A1 and modulates PPARs as a compensatory mechanism in LDL receptor-deficient hamsters

  2020cites this paper
• Simultaneous determination of atorvastatin calcium and ezetimibe in pharmaceutical formulations by liquid chromatography

  2020cites this paper
• An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia

  2020cites this paper
• Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia

  2020cites this paper
• Inhibition of Niemann-Pick C1-like protein 1 by ezetimibe reduces uptake of deuterium-labeled vitamin D in mice.

  2020cites this paper
• A prospective mechanism and source of cholesterol uptake by Plasmodium falciparum-infected erythrocytes co-cultured with HepG2 cells.

  2020cites this paper
• A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

  2020cites this paper
• Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020)

  2020cites this paper
• A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions

  2020cites this paper
• Spectrophotometric Method Development for Simultaneous Estimation for Combination of Rosuvastatin and Curcumin

  2019cites this paper
• The role of the ERK1:STAT1 serine 727 phosphorylation axis on key atherosclerosis associated cellular processes and the anti-atherogenic actions of hydroxytyrosol

  2019cites this paper
• Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis

  2019cites this paper
• A comparative meta-analysis of the efficacy of statin-ezetimibe co-therapy versus statin monotherapy in reducing cardiovascular and cerebrovascular adverse events in patients with type 2 diabetes mellitus.

  2019cites this paper
• Combined Effect of Diosgenin Along with Ezetimibe or Atorvastatin on the Fate of Labelled Bile Acid and Cholesterol in Hypercholesterolemic Rats

  2019cites this paper
• Transintestinal cholesterol excretion in humans

  2018cites this paper
• Synthesis of magnetic nanoparticle-based molecularly imprinted polymer as a selective sorbent for efficient extraction of ezetimibe from biological samples.

  2018cites this paper
• Intestinal absorption of vitamin D: a systematic review

  2018cites this paper
• Opinion on Dietary Reference Values for vitamin

  2018cites this paper
• Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia.

  2018cites this paper
• Role of Ezetimibe in Combination with Statins(Simvastatin and Atorvastatin) in Controlling Dyslipidemia

  2017cites this paper
• Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.

  2017cites this paper
• Inhibitory effect of ezetimibe can be prevented by an administration interval of 4 h between α‐tocopherol and ezetimibe

  2017cites this paper
• Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs

  2017cites this paper
• Factors Regulating Features of Metabolic Syndrome

  2017cites this paper
• The Role of Plant‐derived Products in Pancreatitis: Experimental and Clinical Evidence

  2017cites this paper
• An Approach to Improve Intestinal Absorption of Poorly Absorbed Water-Insoluble Components via Niemann-Pick C1-Like 1.

  2016cites this paper
• High performance liquid chromatographic method for determination of ezetimibe in pharmaceutical formulation tablets

  2016influential citation
• Bivariate and Multivariate Spectrophotometric Methods for Determination of Ezetimibe with Kinetic Study of Its Alkaline Degradation

  2016cites this paper
• DISSOLUTION ENHANCEMENT OF POORLY WATER-SOLUBLE DRUG BY CYCLODEXTRINS INCLUSION COMPLEXATION

  2016cites this paper
• Effects of Combination of Ezetimibe and Rosuvastatin on Coronary Artery Plaque in Patients with Coronary Heart Disease.

  2016cites this paper
• Combination of Ezetimibe and Garlic Reduces Serum Lipids and Intestinal Niemann-Pick C1-like 1 Expression More Effectively in Hypercholesterolemic Mice

  2015cites this paper
• Investigation of reduction process and related impurities in ezetimibe.

  2015cites this paper
• Aminolysis of ezetimibe.

  2015cites this paper
• Efficacy of Ezetimibe Is Not Related to NPC1L1 Gene Polymorphisms in a Pilot Study of Chilean Hypercholesterolemic Subjects

  2015cites this paper
• Dietary effects of housefly (Musca domestica) (Diptera: Muscidae) pupae on the growth performance and the resistance against bacterial pathogen in red sea bream (Pagrus major) (Perciformes: Sparidae)

  2015cites this paper
• Effect of Pretreatment of Ezetimibe/Simvastatin on Arterial Healing and Endothelialization after Drug-Eluting Stent Implantation in a Porcine Coronary Restenosis Model

  2015cites this paper
• Treat To Target Familial Hypercholesterolemia -A prospective study on effects from maximal high intensive treatment of FH patients during eight years

  2015cites this paper
• A NOVEL ENANTIO-SELECTIVE REVERSE PHASE HPLC METHOD FOR THE DETERMINATION OF EZETIMIBE AND IT'S ENANTIOMER

  2015cites this paper
• Scientific Opinion on Dietary Reference Values for vitamin A

  2015cites this paper
• Development and validation of a stability-indicating RP-LC method for the determination of rosuvastatin calcium and ezetimibe in the presence of their acid degradation products in bulk drug, mixture and pharmaceutical preparations with kinetic study of rosuvastatin and ezetimibe acid degradation

  2014cites this paper
• Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects.

  2014cites this paper
• Antidyslipidemic effects of a farnesoid X receptor antagonist in primates.

  2014cites this paper
• The I n Vivo Biochemical and Oxidative Change by Garlic and Ezetimibe Combination in Hypercholesterolemic Mice

  2014cites this paper
• ABSORBANCE SUBTRACTION AND AMPLITUDE MODULATION AS NOVEL SPECTROPHOTOMETRIC METHODS FOR THE ANALYSIS OF BINARY MIXTURES

  2014influential citation
• Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters

  2014cites this paper
• Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review.

  2014cites this paper
• β-lactoglobulin as a vector for β-carotene food fortification.

  2014cites this paper
• Pharmacological Research of a Farnesoid X Receptor Antagonist as an Antidyslipidemic Drug

  2014cites this paper
• Kinetics and mechanism of the base-catalyzed rearrangement and hydrolysis of ezetimibe.

  2014influential citation
• Effect of Ezetimibe on some biochemical factors and expression of Intestinal Scavenger receptor class B type I (SR-BI) in obsess mouse

  2014cites this paper
• Application of a novel UPLC–MS/MS method for the pharmacokinetic/bioequivalence determination of atorvastatin and ezetimibe in human plasma

  2013cites this paper
• Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol

  2013cites this paper
• Regulation of cholesterol homeostasis.

  2013cites this paper
• Isolation and Characterization of R-Enantiomer in Ezetimibe

  2013cites this paper
• Studies on the regulation of hepatic and intestinal lipid metabolism.

  2013cites this paper
• Simultaneous determination of some cholesterol-lowering drugs in their binary mixture by novel spectrophotometric methods.

  2013cites this paper
• Evaluation of Simvastatin and/or Ezetimibe Treatment on Some Diabetic Complications in Streptozotocin Induced Diabetes in rats

  2013cites this paper
• Update on medical management of dyslipidemia and atherosclerosis.

  2013cites this paper
• New insights into the molecular mechanism of intestinal fatty acid absorption

  2013cites this paper
• Stability Indicating RP-HPLC Method for Determination of Ezetimibe in Pure and Pharmaceutical Formulation

  2013cites this paper
• [Use of ezetimibe in the treatment of familial hypercholesterolemia in children and adolescents].

  2012cites this paper
• Towards novel strategies to improve lipid homeostasis - targeting the intestine

  2012cites this paper
• Efeitos da associação de sinvastatina e ezetimiba na cinética de quilomícrons artificiais em pacientes portadores de doença arterial coronária estável

  2012cites this paper
• Beneficial Effects of Silymarin on Lipid Profile in Hyperlipidemic Patients: Placebo Controlled Clinical Trail

  2012cites this paper
• Ezetimibe Inhibits Lymphatic Transport of Esterified Cholesterol but Not Free Cholesterol in Thoracic Lymph Duct-Cannulated Rats

  2012cites this paper
• Enhancement of Intestinal Permeability Utilizing Solid Lipid Nanoparticles Increases γ-Tocotrienol Oral Bioavailability

  2012cites this paper
• Ezetimibe Ameliorates Intestinal Chylomicron Overproduction and Improves Glucose

  2012cites this paper
• Digestion and Intestinal Absorption of Dietary Carotenoids and Vitamin A

  2012cites this paper
• DETERMINATION OF SIMVASTATIN AND EZATIMIBE IN COMBINED TABLET DOSAGE FORMS BY CONSTANT CENTER SPECTROPHOTOMETRIC METHOD

  2012cites this paper
• Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance.

  2012cites this paper
• Ezetimibe, an inhibitor of Niemann-Pick C1-like 1 protein, decreases cholesteryl ester transfer protein in type 2 diabetes mellitus.

  2012cites this paper
• Mechanisms involved in the intestinal absorption of dietary vitamin A and provitamin A carotenoids.

  2012cites this paper
• Cholesterol Absorption Inhibitors for the Treatment of Hypercholesterolaemia

  2012cites this paper
• Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides.

  2012cites this paper
• Spectrofluorometric Determination of Certain Antihyperlipidemic Agents in Bulk and Pharmaceutical Preparations

  2012cites this paper
• Development and Validation of Chiral HPLC Method for Identification and Quantification of (R)-Enantiomer in Ezetimibe

  2012cites this paper
• Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease

  2012cites this paper
• Role and Clinical Consequences of Human UDP-Glucuronosyltransferases

  2012cites this paper
• Squalene monooxygenase – a target for hypercholesterolemic therapy

  2011cites this paper
• Isolation and structure elucidation of major alkaline degradant of ezetimibe.

  2011cites this paper
• Astragalus Polysaccharides Lowers Plasma Cholesterol through Mechanisms Distinct from Statins

  2011cites this paper